Furthermore, as combinatorial therapeutic approaches may be required to obtain significant therapeutic progress, the ability of statins to potentiate the anti-proliferative effect of PLA2G7 impairment in prostate cancer cells was investigated. Here, PLA2G7 is linked to prostate carcinoma.